ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer

BACKGROUND: Current studies on the role of ARHGAP39 mainly focused on its effect on neurodevelopment. However, there are few studies on the comprehensive analysis of ARHGAP39 in breast cancer. METHODS: ARHGAP39 expression level was analyzed based on the Cancer Genome Atlas (TCGA), the Genotype-Tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Litong, Li, Yuwei, Li, Siyuan, Wang, Mozhi, Cao, Hongyi, Xu, Ling, Xu, Yingying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184379/
https://www.ncbi.nlm.nih.gov/pubmed/37189064
http://dx.doi.org/10.1186/s12885-023-10904-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184379/
https://www.ncbi.nlm.nih.gov/pubmed/37189064
http://dx.doi.org/10.1186/s12885-023-10904-4

Ejemplares similares